PMID- 29747140 OWN - NLM STAT- MEDLINE DCOM- 20190114 LR - 20190114 IS - 1573-2517 (Electronic) IS - 0165-0327 (Linking) VI - 236 DP - 2018 Aug 15 TI - Short-term escitalopram treatment normalizes aberrant self-referential processing in major depressive disorder. PG - 222-229 LID - S0165-0327(17)32281-4 [pii] LID - 10.1016/j.jad.2018.04.096 [doi] AB - BACKGROUND: Increased self-focus and negative self-concept play an important role in depression. Antidepressants influence self-referential processing in healthy volunteers, but their function in self-processing of depressed patients remains unknown. METHODS: Thirty-two depressed patients were randomly allocated to receive either escitalopram 10 mg or placebo for one week. After one week, neural responses to positive and negative self-referential adjectives and neutral control stimuli were assessed with functional magnetic resonance imaging. A group of matched healthy volunteers served as a control group. RESULTS: Escitalopram decreased responses of medial fronto-parietal regions to self-referential words relative to non-emotional control stimuli, driven by increased responses to the control condition. Escitalopram also increased responses in the pre-defined region of the medial prefrontal cortex (MPFC) and the anterior cingulate cortex (ACC) to positive relative to negative words. Importantly, the changes in neural responses occurred before any effect on depressive symptoms, implying a direct effect of escitalopram. Furthermore, the placebo group had decreased responses of the MPFC and the ACC to positive self-referential processing relative to the matched healthy controls. However, neural responses of the escitalopram group and the healthy unmedicated controls were similar. LIMITATIONS: Differences between the groups in self-reported depression symptoms and personality traits may have influenced the results. CONCLUSION: One-week treatment with escitalopram normalized aberrant self-referential processing in depressed patients, shifting the focus from the self to the external environment and potentiating positive self-referential processing. This may be an important factor in mechanism of action of antidepressants. CI - Copyright (c) 2018 Elsevier B.V. All rights reserved. FAU - Komulainen, Emma AU - Komulainen E AD - University of Helsinki and Helsinki University Hospital, Psychiatry, Helsinki, Finland. Electronic address: emma.komulainen@helsinki.fi. FAU - Heikkila, Roope AU - Heikkila R AD - University of Helsinki and Helsinki University Hospital, Psychiatry, Helsinki, Finland. FAU - Nummenmaa, Lauri AU - Nummenmaa L AD - Turku PET Centre and Department of Psychology, University of Turku, Finland. FAU - Raij, Tuukka T AU - Raij TT AD - University of Helsinki and Helsinki University Hospital, Psychiatry, Helsinki, Finland; Aalto University, School of Science, Department of Neuroscience and Biomedical Engineering, Espoo, Finland; Aalto NeuroImaging, Aalto University, Espoo, Finland. FAU - Harmer, Catherine J AU - Harmer CJ AD - University Department of Psychiatry, Oxford, UK. FAU - Isometsa, Erkki AU - Isometsa E AD - University of Helsinki and Helsinki University Hospital, Psychiatry, Helsinki, Finland. FAU - Ekelund, Jesper AU - Ekelund J AD - University of Turku and Turku University Hospital, Turku, Finland. LA - eng PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't DEP - 20180422 PL - Netherlands TA - J Affect Disord JT - Journal of affective disorders JID - 7906073 RN - 0 (Antidepressive Agents) RN - 0 (Antidepressive Agents, Second-Generation) RN - 0DHU5B8D6V (Citalopram) SB - IM MH - Adult MH - Antidepressive Agents/*pharmacology MH - Antidepressive Agents, Second-Generation/*therapeutic use MH - Citalopram/*therapeutic use MH - Depressive Disorder, Major/*drug therapy/psychology MH - Double-Blind Method MH - Emotions/*drug effects MH - Female MH - Gyrus Cinguli/physiopathology MH - Humans MH - Magnetic Resonance Imaging/methods MH - Male MH - Prefrontal Cortex/physiopathology MH - *Self Concept MH - Treatment Outcome OTO - NOTNLM OT - Antidepressant OT - Depression OT - Emotion OT - Escitalopram OT - Self-referential processing OT - fMRI EDAT- 2018/05/11 06:00 MHDA- 2019/01/15 06:00 CRDT- 2018/05/11 06:00 PHST- 2017/11/13 00:00 [received] PHST- 2018/03/25 00:00 [revised] PHST- 2018/04/08 00:00 [accepted] PHST- 2018/05/11 06:00 [pubmed] PHST- 2019/01/15 06:00 [medline] PHST- 2018/05/11 06:00 [entrez] AID - S0165-0327(17)32281-4 [pii] AID - 10.1016/j.jad.2018.04.096 [doi] PST - ppublish SO - J Affect Disord. 2018 Aug 15;236:222-229. doi: 10.1016/j.jad.2018.04.096. Epub 2018 Apr 22.